News
Sportschosun on MSN7d
What's multiple myeloma that's the cause of death in an official ceremony?The main character 'Gwansik' in the recently popular Netflix drama 'I've been tricked' has died of multiple myeloma, making ...
Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with ...
11d
MedPage Today on MSNFor Your Patients: Know the Symptoms of Multiple MyelomaWhile there is no cure for multiple myeloma, increased awareness about the symptoms can be the key to timely diagnosis and ...
A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients ...
A real-world study has reinforced the efficacy and safety of teclistamab in heavily pretreated patients with ...
Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.
Early infection incidence in patients with multiple myeloma following treatment with cilta-cel infusion highlights the ...
Birmingham researchers have received £230k of translational funding from Cancer Research Horizons to develop a prototype for a new test to monitor people at risk of developing the blood cancer ...
3d
News-Medical.Net on MSNSurface light chain expression in B-ALL after myeloma treatment: A unique case reportTherapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence.
Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human disease through the analysis of chromosomal ...
Marc Raab, MD, PhD, discussed the MajesTEC-5 trial of teclistamab plus standard myeloma therapies in transplant-eligible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results